JP2021525541A - 変異体Cpf1エンドヌクレアーゼ - Google Patents
変異体Cpf1エンドヌクレアーゼ Download PDFInfo
- Publication number
- JP2021525541A JP2021525541A JP2020567958A JP2020567958A JP2021525541A JP 2021525541 A JP2021525541 A JP 2021525541A JP 2020567958 A JP2020567958 A JP 2020567958A JP 2020567958 A JP2020567958 A JP 2020567958A JP 2021525541 A JP2021525541 A JP 2021525541A
- Authority
- JP
- Japan
- Prior art keywords
- seq
- cpf1
- nucleic acid
- target nucleic
- ortholog
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
- C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
- C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2527/00—Reactions demanding special reaction conditions
- C12Q2527/101—Temperature
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2563/00—Nucleic acid detection characterized by the use of physical, structural and functional properties
- C12Q2563/107—Nucleic acid detection characterized by the use of physical, structural and functional properties fluorescence
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pathology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024226441A JP2025075025A (ja) | 2018-06-04 | 2024-12-23 | 変異体Cpf1エンドヌクレアーゼ |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18175707 | 2018-06-04 | ||
| EP18175707.1 | 2018-06-04 | ||
| EP18190950 | 2018-08-27 | ||
| EP18190950.8 | 2018-08-27 | ||
| PCT/EP2019/064444 WO2019233990A1 (en) | 2018-06-04 | 2019-06-04 | Mutant cpf1 endonucleases |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024226441A Division JP2025075025A (ja) | 2018-06-04 | 2024-12-23 | 変異体Cpf1エンドヌクレアーゼ |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021525541A true JP2021525541A (ja) | 2021-09-27 |
| JP2021525541A5 JP2021525541A5 (cg-RX-API-DMAC7.html) | 2022-07-05 |
Family
ID=66676556
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020567958A Pending JP2021525541A (ja) | 2018-06-04 | 2019-06-04 | 変異体Cpf1エンドヌクレアーゼ |
| JP2024226441A Pending JP2025075025A (ja) | 2018-06-04 | 2024-12-23 | 変異体Cpf1エンドヌクレアーゼ |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024226441A Pending JP2025075025A (ja) | 2018-06-04 | 2024-12-23 | 変異体Cpf1エンドヌクレアーゼ |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US12152257B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3802806A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2021525541A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20210028163A (cg-RX-API-DMAC7.html) |
| CN (1) | CN112424349A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2019282094A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112020024736A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3102676A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL279153A (cg-RX-API-DMAC7.html) |
| MA (1) | MA52739A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2020013229A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2019233990A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3204496A1 (en) | 2014-10-10 | 2017-08-16 | Editas Medicine, Inc. | Compositions and methods for promoting homology directed repair |
| EP3652312A1 (en) | 2017-07-14 | 2020-05-20 | Editas Medicine, Inc. | Systems and methods for targeted integration and genome editing and detection thereof using integrated priming sites |
| AU2019291918B2 (en) | 2018-06-29 | 2025-06-12 | Editas Medicine, Inc. | Synthetic guide molecules, compositions and methods relating thereto |
| CN111521781B (zh) * | 2020-02-24 | 2021-07-30 | 广州医科大学附属第一医院(广州呼吸中心) | 一种用于新冠肺炎病毒SARS-CoV-2核酸的检测试剂盒及其检测方法 |
| CN116848241A (zh) * | 2020-12-17 | 2023-10-03 | 孟山都技术公司 | 工程化无ssDNA酶的CRISPR核酸内切酶 |
| US20240110163A1 (en) | 2021-01-29 | 2024-04-04 | Wageningen Universiteit | Crispr-associated based-editing of the complementary strand |
| EP4441209A4 (en) * | 2021-11-29 | 2025-12-17 | Editas Medicine Inc | MANIPULATED CRISPR/Cas12A EFFECT PROTEINS AND USES THEM |
| EP4486879A1 (en) | 2022-03-01 | 2025-01-08 | Wageningen Universiteit | Cas12a nickases |
| EP4499819A1 (en) | 2022-03-30 | 2025-02-05 | Basf Agricultural Solutions Seed Us Llc | Optimized base editors |
| WO2024105633A1 (en) | 2022-11-18 | 2024-05-23 | Kyoto Prefectural Public University Corporation | Compositions for mitophagy induction and uses thereof |
| EP4638470A1 (en) | 2022-12-21 | 2025-10-29 | BASF Agricultural Solutions US LLC | Increased editing efficiency by co-delivery of rnp with nucleic acid |
| AU2024309386A1 (en) | 2023-06-30 | 2025-12-18 | Christiana Care Gene Editing Institute, Inc. | Nras gene knockout for treatment of cancer |
| WO2025213016A2 (en) | 2024-04-04 | 2025-10-09 | Christiana Care Gene Editing Institute, Inc. | Crispr/cas gene editing of neh4 and/or neh5 domains in nrf2 |
| WO2025226816A1 (en) | 2024-04-23 | 2025-10-30 | Christiana Care Gene Editing Institute, Inc. | Methods of identifying and correlating crispr-induced exon skipping to phenotypic outcomes |
| CN119506249B (zh) * | 2024-11-29 | 2025-11-07 | 大连理工大学 | 一种多PAM选择的基因编辑系统NovaCas-1及其应用 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3009511A2 (en) * | 2015-06-18 | 2016-04-20 | The Broad Institute, Inc. | Novel crispr enzymes and systems |
| WO2017064546A1 (en) * | 2015-09-24 | 2017-04-20 | Crispr Therapeutics Ag | Novel family of rna-programmable endonucleases and their uses in genome editing and other applications |
| WO2017106657A1 (en) * | 2015-12-18 | 2017-06-22 | The Broad Institute Inc. | Novel crispr enzymes and systems |
| WO2018027078A1 (en) * | 2016-08-03 | 2018-02-08 | President And Fellows Of Harard College | Adenosine nucleobase editors and uses thereof |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10648020B2 (en) | 2015-06-18 | 2020-05-12 | The Broad Institute, Inc. | CRISPR enzymes and systems |
| WO2017070632A2 (en) | 2015-10-23 | 2017-04-27 | President And Fellows Of Harvard College | Nucleobase editors and uses thereof |
| KR20260004568A (ko) | 2016-04-19 | 2026-01-08 | 더 브로드 인스티튜트, 인코퍼레이티드 | 신규한 crispr 효소 및 시스템 |
| EP3445853A1 (en) | 2016-04-19 | 2019-02-27 | The Broad Institute, Inc. | Cpf1 complexes with reduced indel activity |
| CN106244591A (zh) * | 2016-08-23 | 2016-12-21 | 苏州吉玛基因股份有限公司 | 修饰crRNA在CRISPR/Cpf1基因编辑系统中的应用 |
| AU2017302551B2 (en) | 2016-07-26 | 2023-04-27 | The General Hospital Corporation | Variants of CRISPR from Prevotella and Francisella 1 (Cpf1) |
| KR20240007715A (ko) | 2016-10-14 | 2024-01-16 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 핵염기 에디터의 aav 전달 |
| WO2018074979A1 (en) | 2016-10-17 | 2018-04-26 | Nanyang Technological University | Truncated crispr-cas proteins for dna targeting |
| IL306092A (en) | 2017-03-23 | 2023-11-01 | Harvard College | Nucleic base editors that include nucleic acid programmable DNA binding proteins |
| EP3612204A4 (en) | 2017-04-21 | 2021-01-27 | The General Hospital Corporation | INDUCTIBLE, TUNING AND MULTIPLEX HUMAN GENE REGULATION USING CRISPR-CPF1 |
| WO2018195545A2 (en) | 2017-04-21 | 2018-10-25 | The General Hospital Corporation | Variants of cpf1 (cas12a) with altered pam specificity |
| US11834665B2 (en) | 2017-05-10 | 2023-12-05 | Regents Of The University Of Minnesota | Programmable transcription factors and methods |
| KR102678809B1 (ko) | 2017-05-18 | 2024-06-26 | 더 브로드 인스티튜트, 인코퍼레이티드 | 표적화된 핵산 편집을 위한 시스템, 방법 및 조성물 |
| EP3625342B1 (en) | 2017-05-18 | 2022-08-24 | The Broad Institute, Inc. | Systems, methods, and compositions for targeted nucleic acid editing |
| KR102655021B1 (ko) | 2017-07-11 | 2024-04-04 | 시그마-알드리치 컴퍼니., 엘엘씨 | 표적된 게놈 변형을 개선하기 위한 뉴클레오솜 상호작용 단백질 도메인 사용 |
| EP3658573A1 (en) | 2017-07-28 | 2020-06-03 | President and Fellows of Harvard College | Methods and compositions for evolving base editors using phage-assisted continuous evolution (pace) |
| WO2019051097A1 (en) | 2017-09-08 | 2019-03-14 | The Regents Of The University Of California | RNA-GUIDED ENDONUCLEASE FUSION POLYPEPTIDES AND METHODS OF USING SAME |
| WO2019075197A1 (en) | 2017-10-11 | 2019-04-18 | The General Hospital Corporation | METHODS OF DETECTION OF INDIVIDUAL SITE-SPECIFIC PARASITE GENOMIC DEAMINATION BY BASE EDITING TECHNOLOGIES |
| WO2019126762A2 (en) | 2017-12-22 | 2019-06-27 | The Broad Institute, Inc. | Cas12a systems, methods, and compositions for targeted rna base editing |
| CN111788232A (zh) | 2018-02-23 | 2020-10-16 | 上海科技大学 | 用于碱基编辑的融合蛋白 |
| EP3660152A4 (en) | 2018-03-26 | 2020-07-15 | National University Corporation Kobe University | METHOD FOR MODIFYING A TARGET SITE IN DOUBLE-STRANDED DNA IN A CELL |
| AU2019255789B2 (en) | 2018-04-19 | 2025-11-20 | The Regents Of The University Of California | Compositions and methods for gene editing |
-
2019
- 2019-06-04 CA CA3102676A patent/CA3102676A1/en active Pending
- 2019-06-04 EP EP19727424.4A patent/EP3802806A1/en not_active Withdrawn
- 2019-06-04 US US15/734,839 patent/US12152257B2/en active Active
- 2019-06-04 MA MA052739A patent/MA52739A/fr unknown
- 2019-06-04 JP JP2020567958A patent/JP2021525541A/ja active Pending
- 2019-06-04 CN CN201980047153.2A patent/CN112424349A/zh active Pending
- 2019-06-04 WO PCT/EP2019/064444 patent/WO2019233990A1/en not_active Ceased
- 2019-06-04 BR BR112020024736-7A patent/BR112020024736A2/pt unknown
- 2019-06-04 KR KR1020207037564A patent/KR20210028163A/ko not_active Ceased
- 2019-06-04 AU AU2019282094A patent/AU2019282094A1/en not_active Abandoned
- 2019-06-04 MX MX2020013229A patent/MX2020013229A/es unknown
-
2020
- 2020-12-02 IL IL279153A patent/IL279153A/en unknown
-
2024
- 2024-10-24 US US18/925,815 patent/US20250163394A1/en active Pending
- 2024-12-23 JP JP2024226441A patent/JP2025075025A/ja active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3009511A2 (en) * | 2015-06-18 | 2016-04-20 | The Broad Institute, Inc. | Novel crispr enzymes and systems |
| WO2017064546A1 (en) * | 2015-09-24 | 2017-04-20 | Crispr Therapeutics Ag | Novel family of rna-programmable endonucleases and their uses in genome editing and other applications |
| WO2017106657A1 (en) * | 2015-12-18 | 2017-06-22 | The Broad Institute Inc. | Novel crispr enzymes and systems |
| WO2018027078A1 (en) * | 2016-08-03 | 2018-02-08 | President And Fellows Of Harard College | Adenosine nucleobase editors and uses thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| MA52739A (fr) | 2021-04-21 |
| CA3102676A1 (en) | 2019-12-12 |
| KR20210028163A (ko) | 2021-03-11 |
| IL279153A (en) | 2021-01-31 |
| BR112020024736A2 (pt) | 2021-03-23 |
| MX2020013229A (es) | 2021-04-28 |
| WO2019233990A1 (en) | 2019-12-12 |
| EP3802806A1 (en) | 2021-04-14 |
| JP2025075025A (ja) | 2025-05-14 |
| US20250163394A1 (en) | 2025-05-22 |
| US20210230567A1 (en) | 2021-07-29 |
| US12152257B2 (en) | 2024-11-26 |
| AU2019282094A1 (en) | 2021-01-07 |
| CN112424349A (zh) | 2021-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20250163394A1 (en) | Mutant Cpf1 Endonucleases | |
| JP7605852B2 (ja) | クラスiiのv型crispr系 | |
| EP3814527B1 (en) | Crispr effector system based amplification methods, systems, and diagnostics | |
| US20210207203A1 (en) | Crispr double nickase based amplification compositions, systems, and methods | |
| US20240169179A2 (en) | Novel class 2 type ii and type v crispr-cas rna-guided endonucleases | |
| US20240271129A1 (en) | Rna-guided cas nucleases and uses thereof in diagnostics and therapy | |
| EP3768855B1 (en) | Methods and compositions for recombinase-mediated selective cleavage of nucleic acids | |
| JP2024521876A (ja) | 変異体Cas12jエンドヌクレアーゼ | |
| Ito et al. | Site-selective scission of human genome by artificial restriction DNA cutter | |
| AU2005233276A1 (en) | A method for selectively detecting subsets of nucleic acid molecules | |
| CN116179511A (zh) | Cpf1蛋白在制备用于核酸检测的试剂盒中的应用 | |
| JP5763111B2 (ja) | 分子的認識によって作用する新規な検出プローブ | |
| CN112342213B (zh) | 核酸分子及其应用 | |
| Kuzuya et al. | DNA, PNA, and their derivatives for precise genotyping of SNPs | |
| CN118599832A (zh) | CRISPR/Cas12a系统直接靶向目标RNA基因并激活核酸酶侧切活性的方法 | |
| MX2007003497A (es) | Ensayo genómico |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220603 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20220603 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220627 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20230417 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20230425 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20230720 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20230922 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20231025 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20231110 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20240208 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20240410 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240510 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20240823 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20241223 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20250122 |